This study of EB-001 to measure safety and efficacy in GL. Single doses of EB- 001 administered through IM injection into procerus at midline and the medial and lateral corrugators will be assessed in healthy subjects with glabellar frown lines.
To evaluate the safety and efficacy of EB-001 compared to placebo in subjects with glabellar frown lines (GL).